PL3825695T3 - Biomarkery u pacjentów, którzy odpowiadają na leczenie z wykorzystaniem terapii AIT - Google Patents
Biomarkery u pacjentów, którzy odpowiadają na leczenie z wykorzystaniem terapii AITInfo
- Publication number
- PL3825695T3 PL3825695T3 PL20200807.4T PL20200807T PL3825695T3 PL 3825695 T3 PL3825695 T3 PL 3825695T3 PL 20200807 T PL20200807 T PL 20200807T PL 3825695 T3 PL3825695 T3 PL 3825695T3
- Authority
- PL
- Poland
- Prior art keywords
- ait
- responders
- biomarkers
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/521—Chemokines
- G01N2333/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1or LDCF-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19211257 | 2019-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3825695T3 true PL3825695T3 (pl) | 2024-04-22 |
Family
ID=68655405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL20200807.4T PL3825695T3 (pl) | 2019-11-25 | 2020-10-08 | Biomarkery u pacjentów, którzy odpowiadają na leczenie z wykorzystaniem terapii AIT |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3825695B1 (pl) |
PL (1) | PL3825695T3 (pl) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2694976A2 (en) * | 2011-04-06 | 2014-02-12 | Stallergenes S.A. | Biomarkers of immunotherapy efficacy |
US11015221B2 (en) * | 2014-10-29 | 2021-05-25 | Stallergenes | Markers of immune response |
ES2826385T3 (es) * | 2016-01-13 | 2021-05-18 | Stallergenes | IL-10 como biomarcador pronóstico de la sensibilidad a la inmunoterapia con alérgenos de ácaros del polvo doméstico |
-
2020
- 2020-10-08 PL PL20200807.4T patent/PL3825695T3/pl unknown
- 2020-10-08 EP EP20200807.4A patent/EP3825695B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3825695C0 (en) | 2023-12-06 |
EP3825695B1 (en) | 2023-12-06 |
EP3825695A3 (en) | 2021-07-28 |
EP3825695A2 (en) | 2021-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL292727A (en) | Multispecific antibodies | |
GB201908045D0 (en) | Object analysis | |
SG11202102505RA (en) | Analyte quantitation | |
GB201900677D0 (en) | Biomarkers | |
GB201910777D0 (en) | Analytical method | |
GB201811093D0 (en) | Biomarker | |
GB202107813D0 (en) | Biomarker | |
SG11202110589PA (en) | Biomarkers for selinexor | |
EP3825695C0 (en) | BIOMARKERS FOR TIA RESPONDENTS | |
EP4076343C0 (en) | RETINOL BASED SERUM | |
GB2585410B (en) | Analysis | |
GB2596002B (en) | Object analysis | |
GB201914183D0 (en) | Biomarker | |
GB201913846D0 (en) | Biomarker | |
GB201913612D0 (en) | Biomarker | |
GB201912154D0 (en) | Biomarker | |
GB201911078D0 (en) | Biomarker | |
GB201915228D0 (en) | Biomarkers | |
GB201902077D0 (en) | Biomarkers | |
GB201902070D0 (en) | Biomarkers | |
GB202114656D0 (en) | Biomarker | |
GB202112831D0 (en) | Biomarker | |
GB202110365D0 (en) | Biomarker | |
GB202014824D0 (en) | Biomarker | |
EP4208321A4 (en) | MICROTOME |